In summary, our results indicate that CB1 and CB2 expression levels have potential as biomarkers for the survival of patients with NSCLC, and that THC and CBD could be used to suppress cell proliferation and EMT. This evidence concerns the gene CNR2 and non-small cell lung carcinoma.